These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3779715)

  • 21. Radioimaging of light chain amyloid with a fibril-reactive monoclonal antibody.
    Wall JS; Kennel SJ; Paulus M; Gregor J; Richey T; Avenell J; Yap J; Townsend D; Weiss DT; Solomon A
    J Nucl Med; 2006 Dec; 47(12):2016-24. PubMed ID: 17138745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (99m)Tc-labeled murine ior C5 monoclonal antibody in colorectal carcinoma patients: pharmacokinetics, biodistribution, absorbed radiation doses to normal organs and tissues and tumor localization.
    Iznaga-Escobar N; Ramos-Suzarte M; Morales-Morales A; Torres-Arocha L; Rodríguez-Mesa N; Pérez-Rodriguez R
    Methods Find Exp Clin Pharmacol; 2004 Nov; 26(9):687-96. PubMed ID: 15632954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma.
    Colcher D; Esteban J; Carrasquillo JA; Sugarbaker P; Reynolds JC; Bryant G; Larson SM; Schlom J
    Cancer Res; 1987 Aug; 47(15):4218-24. PubMed ID: 3607761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
    Lee FT; Rigopoulos A; Hall C; Clarke K; Cody SH; Smyth FE; Liu Z; Brechbiel MW; Hanai N; Nice EC; Catimel B; Burgess AW; Welt S; Ritter G; Old LJ; Scott AM
    Cancer Res; 2001 Jun; 61(11):4474-82. PubMed ID: 11389078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodistribution and dosimetry following infusion of antibodies labeled with large amounts of 131I.
    Badger CC; Davis J; Nourigat C; Wu ZM; Hui TE; Fisher DR; Shulman H; Appelbaum FR; Eary JF; Krohn KA
    Cancer Res; 1991 Nov; 51(21):5921-8. PubMed ID: 1682038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced tumor localization of radiolabeled Fab fragments of monoclonal antibody A7 in nude mice bearing human pancreatic carcinoma xenografts.
    Otsuji E; Yamaguchi T; Yamaoka N; Kato M; Kotani T; Kitamura K; Yamaguchi N; Takahashi T
    Jpn J Cancer Res; 1993 Aug; 84(8):914-20. PubMed ID: 8407556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved radioimmunoscintigraphy of human mammary carcinoma xenografts after injection of an anti-antibody.
    Senekowitsch R; Bode W; Reidel G; Glässner H; Möllenstädt S; Kriegel H; Pabst HW
    Nuklearmedizin; 1987 Feb; 26(1):13-9. PubMed ID: 3495786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude mice.
    Barendswaard EC; Scott AM; Divgi CR; Williams C; Coplan K; Riedel E; Yao TJ; Gansow OA; Finn RD; Larson SM; Old LJ; Welt S
    Int J Oncol; 1998 Jan; 12(1):45-53. PubMed ID: 9454885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodistribution and intraoperative evaluation of radiolabeled monoclonal antibody MX35 in patients with epithelial ovarian cancer.
    Rubin SC; Kostakoglu L; Divgi C; Federici MG; Finstad CL; Lloyd KO; Larson SM; Hoskins WJ
    Gynecol Oncol; 1993 Oct; 51(1):61-6. PubMed ID: 8244176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications.
    Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A
    Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioiodinated B6.2 monoclonal antibody: further characterization of a potential radiopharmaceutical for the identification of breast tumors.
    Zalutsky MR; Colcher D; Kaplan WD; Kufe DW
    Int J Nucl Med Biol; 1985; 12(3):227-33. PubMed ID: 3905666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma.
    Mach JP; Chatal JF; Lumbroso JD; Buchegger F; Forni M; Ritschard J; Berche C; Douillard JY; Carrel S; Herlyn M
    Cancer Res; 1983 Nov; 43(11):5593-600. PubMed ID: 6616486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of pulmonary metastases in a patient with synovial cell sarcoma using In-111 labeled monoclonal antibody 19-24.
    Swift JE; Blend MJ; Bekerman C; Das Gupta TK; Greager JA
    Clin Nucl Med; 1990 Apr; 15(4):227-30. PubMed ID: 2160347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical evaluation of monoclonal antibody 14C5 for targeting pancreatic cancer.
    Vervoort L; Burvenich I; Staelens S; Dumolyn C; Waegemans E; Van Steenkiste M; Baird SK; Scott AM; De Vos F
    Cancer Biother Radiopharm; 2010 Apr; 25(2):193-205. PubMed ID: 20423233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiolabeled monoclonal antibody B72.3 localization in metastatic lesions of colorectal cancer patients.
    Colcher D; Carrasquillo JA; Esteban JM; Sugarbaker P; Reynolds JC; Siler K; Bryant G; Larson SM; Schlom J
    Int J Rad Appl Instrum B; 1987; 14(3):251-62. PubMed ID: 3667307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.
    Smith-Jones PM; Vallabhajosula S; Navarro V; Bastidas D; Goldsmith SJ; Bander NH
    J Nucl Med; 2003 Apr; 44(4):610-7. PubMed ID: 12679407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative dual label study of first and second generation antitumor-associated glycoprotein-72 monoclonal antibodies in colorectal cancer patients.
    Gallinger S; Reilly RM; Kirsh JC; Odze RD; Schmocker BJ; Hay K; Polihronis J; Damani MT; Shpitz B; Stern HS
    Cancer Res; 1993 Jan; 53(2):271-8. PubMed ID: 8417820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics, biodistribution, and dosimetry of specific and control radiolabeled monoclonal antibodies in patients with primary head and neck squamous cell carcinoma.
    Maraveyas A; Stafford N; Rowlinson-Busza G; Stewart JS; Epenetos AA
    Cancer Res; 1995 Mar; 55(5):1060-9. PubMed ID: 7866989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model.
    Burvenich I; Schoonooghe S; Cornelissen B; Blanckaert P; Coene E; Cuvelier C; Mertens N; Slegers G
    Clin Cancer Res; 2005 Oct; 11(20):7288-96. PubMed ID: 16243799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maleimidoethyl 3-(tri-n-butylstannyl)hippurate: a useful radioiodination reagent for protein radiopharmaceuticals to enhance target selective radioactivity localization.
    Arano Y; Wakisaka K; Ohmomo Y; Uezono T; Mukai T; Motonari H; Shiono H; Sakahara H; Konishi J; Tanaka C
    J Med Chem; 1994 Aug; 37(16):2609-18. PubMed ID: 8057303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.